Skip to main content
Clinical Trials/NL-OMON46719
NL-OMON46719CompletedNot Applicable

DIETARY NITRATE INTAKE IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE - Walk-O

Radboud Universiteit Nijmegen0 sites21 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
21

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • •- stable intermittent claudication for at least three month;
  • •- ABI (the ratio of BP in the lower legs to the BP in the arms) <0.9 and/or a ABI decreased by more than 0.15 after treadmill testing regardless of their ABI at rest;
  • •- Rutherford classification for chronic limb ischemia 1-4 and/or Fontaine classification stage IIA-IIB or III.

Exclusion Criteria

  • •- any condition other than PAD that limits walking;
  • •- patients diagnosed with diagnosed with chronic kidney disease and/or or patients with insulin dependent diabetes;
  • •- previous endovascular or surgical treatment for claudication within the last 12 months
  • •- individuals with critical limb ischemia, who are wheel-chair bound, or who have an above or below-knee amputation;
  • •- using dietary nitrate supplements;

Investigators

Similar Trials